Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Levon Demirdjian

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 5, 2025
A Response to the Letter to the Editor: "Flawed FLAURA Comparisons and Non-Random Biomarker Missingness in US Osimertinib Cohort Study"Antonio Passaro, Levon Demirdjian, Yanfang Liu
Journal of Applied Meteorology and Climatology|September 4, 2018
Statistical Modeling of Extreme Precipitation with TRMM DataLevon Demirdjian, Yaping Zhou, George J Huffman
Journal of Psychiatric Research|January 7, 2016
Single nucleotide polymorphism near CREB1, rs7591784, is associated with pretreatment methamphetamine use frequency and outcome of outpatient treatment for methamphetamine use disorderKeith G Heinzerling, Levon Demirdjian, Yingnian Wu, et al.
Genome Biology|July 30, 2017
Population and allelic variation of A-to-I RNA editing in human transcriptomesEddie Park, Jiguang Guo, Shihao Shen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2025
Overall Survival in EGFR-Mutant Advanced NSCLC Treated With First-Line Osimertinib: A Cohort Study Integrating Clinical and Biomarker Data in the United StatesJoshua K Sabari, Helena A Yu, Parthiv J Mahadevia, et al.
American Journal of Human Genetics|August 12, 2020
Detecting Allele-Specific Alternative Splicing from Population-Scale RNA-Seq DataLevon Demirdjian, Yungang Xu, Emad Bahrami-Samani, et al.
Cancer Medicine|February 26, 2025
Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real-World SettingLevon Demirdjian, Spyros Triantos, Kristopher Standish, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2020
Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancersJohn W Phillips, Yang Pan, Brandon L Tsai, et al.
Journal for Immunotherapy of Cancer|June 20, 2020
Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancerAnanth Annapragada, Andrew Sikora, Catherine Bollard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2025
Amivantamab Plus Lazertinib in Atypical <i>EGFR</i>-Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2Pascale Tomasini, Yongsheng Wang, Yongsheng Li, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 5, 2025
A Response to the Letter to the Editor: "Flawed FLAURA Comparisons and Non-Random Biomarker Missingness in US Osimertinib Cohort Study"Antonio Passaro, Levon Demirdjian, Yanfang Liu
Journal of Applied Meteorology and Climatology|September 4, 2018
Statistical Modeling of Extreme Precipitation with TRMM DataLevon Demirdjian, Yaping Zhou, George J Huffman
Journal of Psychiatric Research|January 7, 2016
Single nucleotide polymorphism near CREB1, rs7591784, is associated with pretreatment methamphetamine use frequency and outcome of outpatient treatment for methamphetamine use disorderKeith G Heinzerling, Levon Demirdjian, Yingnian Wu, et al.
Genome Biology|July 30, 2017
Population and allelic variation of A-to-I RNA editing in human transcriptomesEddie Park, Jiguang Guo, Shihao Shen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2025
Overall Survival in EGFR-Mutant Advanced NSCLC Treated With First-Line Osimertinib: A Cohort Study Integrating Clinical and Biomarker Data in the United StatesJoshua K Sabari, Helena A Yu, Parthiv J Mahadevia, et al.
American Journal of Human Genetics|August 12, 2020
Detecting Allele-Specific Alternative Splicing from Population-Scale RNA-Seq DataLevon Demirdjian, Yungang Xu, Emad Bahrami-Samani, et al.
Cancer Medicine|February 26, 2025
Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real-World SettingLevon Demirdjian, Spyros Triantos, Kristopher Standish, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2020
Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancersJohn W Phillips, Yang Pan, Brandon L Tsai, et al.
Journal for Immunotherapy of Cancer|June 20, 2020
Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancerAnanth Annapragada, Andrew Sikora, Catherine Bollard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2025
Amivantamab Plus Lazertinib in Atypical <i>EGFR</i>-Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2Pascale Tomasini, Yongsheng Wang, Yongsheng Li, et al.
Pageof 1